facebook linked in twitter youtube instagram

Nelson Mullins COVID-19 Resources

Nelson Mullins is continuing to monitor developments related to COVID-19, including guidance from the Centers for Disease Control and various federal, state, and local government authorities. The firm is taking appropriate precautionary actions and has implemented plans to ensure the continuation of all firm services to clients from both in office and remote work arrangements across our 25 offices. 

In addition, click the link below to access extensive resources to address a wide variety of topics resulting from the virus, in general and by industry,  including topics such as essential businesses, force majeure, business interruption insurance, CARES Act and FFCRA, and others. 

Nelson Mullins COVID-19 Resources

The LatestView All

Bruce and Wendy Wiener: All Roads Lead to Giving Back

July 30, 2020

Bruce and Wendy Wiener: All Roads Lead to Giving Back
close
Breaking News & Press
(Select month on right to view full report.)

Want the latest reporting on the coronavirus? Sign up for “To Your Health: Coronavirus” a new Washington Post newsletter that will bring you everything you need to know about the spread of the coronavirus in the U.S. and abroad.

  • August 4, 11:11 a.m.

    President Trump held a press conference to brief the public on the Administration’s COVID-19 response. Nationwide, the number of positive cases has declined by nearly 6% from the week before and the positive test rate has also dropped from 8.7% to 8% over that same period of time.

  • August 1, 8:57 a.m.

    President Trump participated in a COVID-19 Response and Storm Preparedness Roundtable in Belleair, Florida where he detailed the latest surge of testing, equipment, and resources to Florida and across the country. 

  • July 27, 5:28 p.m.

    Senate Republicans released their $1 trillion coronavirus relief package, which includes a cut of $400 to the enhanced unemployment benefit for Americans out of work from the COVID-19 crisis.

  • July 24, 9:48 a.m.

    Senate Republicans and the Trump administration could not agree on the particulars of a proposal for coronavirus relief and are expected to announce a proposal early next week.

  • July 23, 6:00 a.m.

    President Trump held a briefing to provide the Nation with an update on vaccines, testing and therapeutics, essential precautions, and reopening schools.

  • July 17, 11:41 a.m.

    The Federal Reserve announced that nonprofits are to be included in its “Main Street” lending program that's designed to help small and medium-sized employers stay afloat during the coronavirus pandemic.

  • July 16, 3:16 p.m.

    On July 15, Georgia Governor Brian Kemp signed an executive order extending COVID-19 restrictions and guidance for businesses and individuals through July 31, 2020. The latest order continues to require individuals with higher risk of severe illness to shelter in place and precludes local governments from adopting more or less restrictive measures relating to COVID-19. 

  • July 16, 10:59 a.m.

    An investigational vaccine designed to protect against COVID-19 prompted neutralizing antibody activity in healthy adults, according to interim results published online today. The ongoing Phase 1 trial is supported by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. 

  • July 8, 11:31 a.m.

    President Trump led a roundtable with teachers, administrators, and students from across the country to discuss the reopening of schools in America.

  • July 2, 4:55 p.m.

    Somewhat unexpectedly this week, the U.S. Senate and House each passed an extension of the Paycheck Protection Program that would extend the loan program for coronavirus-impacted companies from June 30th to August 8th. To the extent the businesses follow the program's guidelines, the debts are forgiven. The President is expected to sign the legislation. The $669 billion program has approved more than 4.8 million loans. There remains an estimated $130 billion available.


Questions?
Please contact Beth Huffman, Director of Marketing, at 803.255.9788